Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
BT-20 | 17-AAG | 0.000302 | uM | 8 | 1250.00 | 622.75 | 2020.00 | 1551.25 | 1.3022 | 1.4441 |
BT-20 | Erlotinib | 10 | uM | 8 | 1250.00 | 622.75 | 1261.00 | 1551.25 | 0.8129 | 0.7089 |
BT-20 | 17-AAG | 0.001 | uM | 8 | 1250.00 | 622.75 | 1600.00 | 1551.25 | 1.0314 | 1.0476 |
BT-20 | Lapatinib | 10 | uM | 8 | 1250.00 | 622.75 | 875.00 | 1551.25 | 0.5641 | 0.2947 |
BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1795.00 | 1551.25 | 1.1571 | 1.2344 | |
BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1549.00 | 1551.25 | 0.9986 | 0.9978 | |
BT-20 | 17-AAG | 0.000066069 | uM | 8 | 1250.00 | 622.75 | 1459.00 | 1551.25 | 0.9405 | 0.9090 |
BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1308.00 | 1551.25 | 0.8432 | 0.7570 | |
BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1537.00 | 1551.25 | 0.9908 | 0.9860 | |
BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1162.00 | 1551.25 | 0.7491 | 0.6060 | |
BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1378.00 | 1551.25 | 0.8883 | 0.8280 | |
BT-20 | Erlotinib | 0.01 | uM | 8 | 1250.00 | 622.75 | 1573.00 | 1551.25 | 1.0140 | 1.0213 |
BT-20 | Erlotinib | 3.1623 | uM | 8 | 1250.00 | 622.75 | 1185.00 | 1551.25 | 0.7639 | 0.6301 |
BT-20 | 17-AAG | 0.31623 | uM | 8 | 1250.00 | 622.75 | 586.00 | 1551.25 | 0.3778 | -0.0451 |
BT-20 | Linsitinib | 19.9526 | uM | 8 | 1250.00 | 622.75 | 1185.00 | 1551.25 | 0.7639 | 0.6301 |
BT-20 | Linsitinib | 0.01 | uM | 8 | 1250.00 | 622.75 | 2164.00 | 1551.25 | 1.3950 | 1.5753 |
BT-20 | Linsitinib | 0.031623 | uM | 8 | 1250.00 | 622.75 | 1826.00 | 1551.25 | 1.1771 | 1.2637 |
BT-20 | Lapatinib | 0.01 | uM | 8 | 1250.00 | 622.75 | 1967.00 | 1551.25 | 1.2680 | 1.3952 |
BT-20 | 17-AAG | 0.031623 | uM | 8 | 1250.00 | 622.75 | 706.00 | 1551.25 | 0.4551 | 0.1000 |
BT-20 | Lapatinib | 0.1 | uM | 8 | 1250.00 | 622.75 | 1821.00 | 1551.25 | 1.1739 | 1.2590 |
BT-20 | Erlotinib | 0.31623 | uM | 8 | 1250.00 | 622.75 | 1715.00 | 1551.25 | 1.1056 | 1.1584 |
BT-20 | Linsitinib | 0.31623 | uM | 8 | 1250.00 | 622.75 | 2043.00 | 1551.25 | 1.3170 | 1.4652 |
BT-20 | Lapatinib | 0.0016596 | uM | 8 | 1250.00 | 622.75 | 1644.00 | 1551.25 | 1.0598 | 1.0902 |
BT-20 | 17-AAG | 0.01 | uM | 8 | 1250.00 | 622.75 | 832.00 | 1551.25 | 0.5363 | 0.2461 |
BT-20 | Lapatinib | 0.031623 | uM | 8 | 1250.00 | 622.75 | 1798.00 | 1551.25 | 1.1591 | 1.2373 |